HomeIndustriesHealthcareELAN CEO on Bird Flu Vaccine for Cattle, Recent Earnings

ELAN CEO on Bird Flu Vaccine for Cattle, Recent Earnings

Jeffrey Simmons, CEO of Elanco (ELAN), discusses their latest quarter as the stock hits a 52-week low after earnings. He also talks about their new partnership with Medgene for a bird flu vaccine for cattle, which is in the final stages of USDA approval. He adds that they sold their aqua business to pay down debt, and says the “quality of growth” of Elanco should be an investor focus.

Morning Trade Live

25 Feb 2025

SHARE

ON AIR
education
6:00 pm
Schwab 2026 Outlook
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
education
5:00 am
Liz Ann Live
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Market Overtime
REPLAY
8:00 am
Market Overtime
REPLAY
8:30 am
Market On Close
REPLAY
education
10:00 am
Schwab 2026 Outlook
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Liz Ann Live
REPLAY
1:30 pm
The Wrap
REPLAY
3:00 pm
Market Overtime
REPLAY
4:00 pm
Market Overtime
REPLAY
4:30 pm
Market On Close
REPLAY
ON AIR
education
6:00 pm
Schwab 2026 Outlook
REPLAY
7:00 pm
Fast Market
REPLAY
8:00 pm
Next Gen Investing
REPLAY
education
9:00 pm
Liz Ann Live
REPLAY
9:30 pm
The Wrap
REPLAY
11:00 pm
Market Overtime
REPLAY

Schwab Network's Newsletters

Daily insights for every investor